| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.0M | +9.6% |
| Cost of Revenue | $2.7M | -57.2% |
| R&D Expense | $20.1M | -14.2% |
| SG&A Expense | $26.2M | +30.0% |
| Operating Income | -$42.0M | +8.0% |
| Pre-tax Income | -$42.3M | +10.2% |
| Income Tax | -$571K | +82.6% |
| Net Income | -$45.2M | -4.1% |
| EPS (Basic) | -$1.74 | -2.4% |
| EPS (Diluted) | -$1.74 | -2.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $185K | -97.8% |
| Short-term Investments | $2.2M | -93.8% |
| Accounts Receivable | $375K | +360.6% |
| Inventory | $909K | — |
| Current Assets | $4.8M | -90.5% |
| Total Assets | $51.0M | -51.1% |
| Current Liabilities | $10.1M | -44.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.5M | -453.2% |
| Capital Expenditures | $2.0M | -90.1% |
| Investing Cash Flow | $32.2M | +193.3% |
| Financing Cash Flow | -$9.0M | -82.4% |
| Free Cash Flow | -$33.5M | -29.8% |
| Total Liabilities |
| $22.7M |
| -28.8% |
| Stockholders' Equity | $31.4M | -57.5% |